Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study

Daniele G;Raspagliesi F;Scambia G;Pisano C;Colombo N;Frezzini S;Tognon G;Artioli G;Gadducci A;Lauria R;Ferrero A;Cinieri S;De Censi A;Breda E;Scollo P;De Giorgi U;Lissoni AA;Katsaros D;Lorusso D;Salutari V;Cecere SC;Zaccarelli E;Nardin M;Bogani G;Distefano M;Greggi S;Piccirillo MC;Fossati R;Giannone G;Arenare L;Gallo C;Perrone F;Pignata S

2021-01-01